Stay updated on Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Sign up to get notified when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new label 'Last Update Posted (Estimated)' appears, replacing the former 'Last Update Posted'.
    Difference
    0.0%
    Check dated 2025-12-31T23:59:53.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Site listings updated: Budapest, Hungary (postal code 1044) and Wroclaw, Poland (postal code 51-685) entries were added/updated, replacing the previous Budapest entry (1138). The Last Update field changed from an estimated date (2025-09) to a concrete date (2025-12-22) and now reads 'Last Update Posted'.
    Difference
    0.1%
    Check dated 2025-12-24T21:49:29.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The Locations section was reformatted to consolidate location entries under a single 'Locations' heading, replacing individual 'State/Region Locations' subheads.
    Difference
    2%
    Check dated 2025-12-17T17:15:49.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The site updated to Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-26T07:22:30.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Removal of the government funding/operating-status notice from the page does not affect the trial details or core information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-19T08:13:11.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Cali, Colombia was added to the study locations and Santiago de Cali, Colombia was removed.
    Difference
    0.3%
    Check dated 2025-10-28T05:10:05.000Z thumbnail image

Stay in the know with updates to Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.